Equities
Swiss equities flat as Logitech, ABB rise; Amrize falls on CFO exit
The SMI traded little changed Tuesday, with Logitech and ABB leading gains while Amrize slumped after its finance chief departed. Swiss franc weakened against the dollar and euro as regional markets tracked mixed European cues.
European stocks rise after Iran sanctions threats fail to materialize
Stoxx Europe 600 gains 0.4% as geopolitical tensions ease; Germany’s Q2 GDP growth beats estimates at 1.0%. Brent crude dips below $92 a barrel.
UBS pushes for softer AT1 capital rules amid Swiss bank reform debate
Swiss lawmakers weigh compromise on Additional-Tier-1 debt as UBS-backed study argues for earlier loss-absorption triggers. Next vote set for Aug. 31.
Germany’s DAX hits record close after sector-led gains
Utilities, chemicals and insurance shares drove the Frankfurt market higher, with the DAX up 0.82% to a record finish. The MDAX and TecDAX also advanced, while gold and oil futures slipped.
German DAX hits record high after Fed’s Warsh signals rate hike risk
German blue-chip index climbs 0.77% to fresh peak after US central bank chief warns of inflation fight; automakers and chemicals lead gains. Euro Stoxx 50 advances 0.95% as risk appetite persists.
European stocks rise as U.S. sanctions on Iran ease crude supply fears
Euro Stoxx 600 gains 0.4% as Brent crude steadies near $91.50; German GDP beats estimates with 1.0% annualized growth in Q2.
Amrize appoints Sam Poletti as CFO, names new IR head
Poletti, a former Holcim executive, succeeds Baris Oran in the CFO role. Dillon Cumming joins as vice president of Investor Relations effective Sept. 8.
Swiss stocks mixed as SMI edges higher; Arbonia plunges on earnings
ABB gains led gains among large caps while Arbonia slumped 9.8% after results; UBS and Vontobel adjusted ratings and price targets for several Swiss equities. The Swiss franc weakened further against the dollar and euro.
DroneShield posts 74% H1 2026 revenue growth, lifts FY guidance
Defense drone detection firm DroneShield reported AUD 126 million in first-half revenue, up 74% year-over-year, while reaffirming full-year guidance and flagging margin pressures from ERP and warehouse moves.
Suncorp shares surge 4.2% on report of Tokio Marine takeover interest
Australian insurer’s stock jumps to A$18.70 after Financial Times cites Tokio Marine’s potential multi-billion-dollar bid. ASX 200 rises 0.7% on Tuesday.
German stocks rise as oil falls; SAP drags DAX lower
DAX advances 0.48% to 26,391 as Brent crude drops over 3% and Euro Stoxx 50 gains 0.5%. SAP falls 3.7% after UBS downgrade; Nvidia awaited after U.S. PCE data.
Palantir CEO sells $86 million in shares under pre-set trading plans
Alexander Karp disposed of 492,348 Class A shares through two Rule 10b5-1 plans, including a $70.3 million tax-withholding sale tied to vested RSUs. Shares traded between $172.19 and $176.37.
German software stocks rise after Salesforce, CrowdStrike earnings beat
SAP, Nemetschek and TeamViewer gain as U.S. peers Salesforce and CrowdStrike post strong quarterly results and lift guidance, easing AI demand concerns.
Intershop profit falls on lower revaluations despite portfolio growth
Swiss real estate firm's first-half net income drops 61% to CHF 67.5m as valuation gains shrink, though operating profit rises 18% and portfolio expands to CHF 1.92bn.
Celcuity files FDA application to expand breast cancer drug REVTORPYK label
Supplemental New Drug Application targets HR+/HER2- breast cancer patients with PIK3CA mutations. Phase 3 data showed 50% reduction in progression risk.
Pelosi buys Bloom Energy and Intel shares, invests in San Francisco hotel
U.S. Representative Nancy Pelosi disclosed purchases of Bloom Energy and Intel stock last month, alongside a $500,000-$1 million investment in a San Francisco luxury hotel property. Bloom Energy shares rose 320% over the past year.
Senhwa completes enrollment in Phase 1b cancer drug trial
Taiwan’s Senhwa Biosciences finishes patient enrollment for CX-5461 trial in advanced solid tumors with BRCA1/2 or related mutations. Clinical Study Report due Q1 2027.
SentinelOne shares fall 6.4% after weak profit guidance overshadows revenue beat
Cybersecurity firm posts Q2 revenue of $292 million, beating estimates, but forecasts for adjusted EPS miss consensus for current and fiscal 2027 quarters.
Feintool posts H1 2026 profit rebound, shares rise 4%
Feintool International Holding AG reported a 5.6% rise in H1 sales, swung to a CHF 8.8 million EBIT and posted its first positive net result since 2023, sending the stock up about 4%.
RATIONAL AG posts 8% organic growth in H1 2026, China sales decline persists
German kitchen equipment maker RATIONAL AG reported EUR 642 million in H1 2026 sales with EBIT rising 11% to EUR 170 million. China remains a drag on growth despite new product launches.
Nvidia lifts U.S. tech futures ahead of Wall Street open; SMI slips on heavyweights
Nvidia’s strong outlook drove semiconductor stocks higher in premarket trading, while Swiss blue chips fell as Nestlé, Novartis and Roche weighed on the SMI. Focus shifts to Jackson Hole Fed symposium.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Volkswagen faces internal backlash amid sweeping cuts, Tesla recalls 3 mln cars in China
VW's transformation plan sparks employee criticism; Tesla faces record recall over door-handle safety issues. Plus: Shein's HK IPO targets $1.5 bln, Porsche sells MHP for €320 mln.
Schwyzer Kantonalbank posts 25% rise in H1 profit on strong interest income
Swiss regional lender SZKB reports CHF 47.0 million net profit for first half of 2026, up 25% year-on-year, as net interest income surges 21.9% and business success climbs 22.6%.